In the gastric cancer patients, the TLR9 genotype distribution was 31.33% TT, 51.50% TC, and 17.17% CC in H. pylori-positive patients; and 25.93% TT, 54.32% TC, and 19.75% CC in H. pylori-negative patients. This evidence concerns the gene TLR9 and gastric cancer.